Antibacterial drugs are among the most important therapeutic advances in medicine, enabling the treatment of bacterial infections that were once frequently fatal. Understanding their classification by mechanism of action, spectrum of activity, and pharmacodynamic properties is essential for rational prescribing and antimicrobial stewardship.
What Are Antibacterial Drugs?
Antibacterials are classified by their mechanism of action (cell wall synthesis inhibition, protein synthesis inhibition, nucleic acid synthesis inhibition, folate synthesis inhibition, or membrane disruption), by spectrum (narrow versus broad), and by effect (bacteriostatic versus bactericidal). Bactericidal agents kill bacteria directly, while bacteriostatic agents inhibit bacterial growth, relying on host immune mechanisms for clearance.
Drug Classes and Mechanisms
Beta-lactams are the largest and most widely used antibiotic class. They inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins, preventing cross-linking of peptidoglycan chains. Penicillins include natural penicillins, aminopenicillins, anti-staphylococcal penicillins, and anti-pseudomonal penicillins. Cephalosporins are grouped into five generations with progressively broader gram-negative coverage. Carbapenems (imipenem, meropenem) have the broadest spectrum of any beta-lactam. Monobactams (aztreonam) target only gram-negative bacteria.
Macrolides (erythromycin, azithromycin, clarithromycin) inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit. They have moderate gram-positive coverage and are important for atypical respiratory pathogens and intracellular organisms.
Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) inhibit DNA gyrase and topoisomerase IV, disrupting DNA replication. They have broad-spectrum activity but are associated with significant adverse effects that have restricted their use.
Tetracyclines (doxycycline, minocycline, tigecycline) bind the 30S ribosomal subunit, inhibiting protein synthesis. They are valuable for atypical infections, acne, and as antimalarial prophylaxis.
Aminoglycosides (gentamicin, tobramycin, amikacin) also target the 30S ribosomal subunit but with concentration-dependent bactericidal activity. Their use is limited by nephrotoxicity and ototoxicity, requiring therapeutic drug monitoring.
Sulfonamides and trimethoprim inhibit sequential steps in bacterial folate synthesis. The combination trimethoprim-sulfamethoxazole provides synergistic activity against a broad range of organisms.
Glycopeptides (vancomycin, teicoplanin) inhibit cell wall synthesis by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors. They are primarily active against gram-positive bacteria including MRSA.
Oxazolidinones (linezolid) inhibit protein synthesis at the 50S ribosomal subunit with a unique mechanism that prevents cross-resistance with other classes.
Therapeutic Uses
Antibiotic selection depends on the suspected or confirmed pathogen, infection site, local resistance patterns, patient allergies, and organ function. Empiric therapy for serious infections should cover the most likely pathogens and be narrowed once culture results are available.
Adverse Effects
Beta-lactams commonly cause hypersensitivity reactions ranging from mild rash to anaphylaxis. Fluoroquinolones are associated with tendonitis, tendon rupture, peripheral neuropathy, and QT prolongation. Aminoglycosides cause nephrotoxicity and ototoxicity. Clostridioides difficile infection is a potentially severe complication of almost all antibiotics.
Key Clinical Considerations
Antibiotic resistance is an escalating global threat driven by overuse and misuse. Shorter courses of therapy are increasingly recommended for common infections. Prolonged or broad-spectrum antibiotic use disrupts the microbiome and promotes resistance. Penicillin allergy labels should be verified, as over 90 percent of labeled patients tolerate penicillins on testing.
Conclusion
Antibacterial drugs remain essential in modern medicine, but their effectiveness is threatened by rising resistance. Rational prescribing based on infection type, pathogen susceptibility, and stewardship principles preserves these vital agents for future generations.
